PT - JOURNAL ARTICLE AU - Oliveira, Juliane F. AU - Jorge, Daniel C. P. AU - Veiga, Rafael V. AU - Rodrigues, Moreno S. AU - Torquato, Matheus F. AU - da Silva, Nívea B. AU - Fiaconne, Rosemeire L. AU - Castro, Caio P. AU - Paiva, Aureliano S. S. AU - Cardim, Luciana L. AU - Amad, Alan A. S. AU - Lima, Ernesto A. B. F. AU - Souza, Diego S. AU - Pinho, Suani T. R. AU - Ramos, Pablo I. P. AU - Andrade, Roberto F. S. AU - , TI - Evaluating the burden of COVID-19 on hospital resources in Bahia, Brazil: A modelling-based analysis of 14.8 million individuals AID - 10.1101/2020.05.25.20105213 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.25.20105213 4099 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20105213.short 4100 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20105213.full AB - Here we present a general compartment model with a time-varying transmission rate to describe the dynamics of the COVID-19 epidemic, parameterized with the demographics of Bahia, a state in northeast Brazil. The dynamics of the model are influenced by the number of asymptomatic cases, hospitalization requirements and mortality due to the disease. A locally-informed model was determined using actual hospitalization records. Together with cases and casualty data, optimized estimates for model parameters were obtained within a metaheuristic framework based on Particle Swarm Optimization. Our strategy is supported by a statistical sensitivity analysis on the model parameters, adequate to properly account for the simulated scenarios. First, we evaluated the effect of previously enforced interventions on the transmission rate. Then, we studied its effects on the number of deaths as well as hospitalization requirements, considering the state as a whole. Special attention is given to the impact of asymptomatic individuals on the dynamic of COVID-19 transmission, as these were estimated to contribute to a 68% increase in the basic reproductive number. Finally, we delineated scenarios that can set guides to protect the health care system, particularly by keeping demand below total bed occupancy. Our results underscore the challenges related to maintaining a fully capable health infrastructure during the ongoing COVID-19 pandemic, specially in a low-resource setting such as the one focused in this work. The evidences produced by our modelling-based analysis show that decreasing the transmission rate is paramount to success in maintaining health resources availability, but that current local efforts, leading to a 38% decrease in the transmission rate, are still insufficient to prevent its collapse at peak demand. Carefully planned and timely applied interventions, that result in stark decreases in transmission rate, were found to be the most effective in preventing hospital bed shortages for the longest periods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES), Finance Code 001. STRP was supported by an International Cooperation grant (process number INT0002/2016) from Bahia Research Foundation (FAPESB). STRP and RFSA were supported by the National Institute of Science and Technology - Complex Systems from CNPq, Brazil. JFO was supported by the Center of Data and Knowledge Integration for Health (CIDACS) through the Zika Platform- a long-term surveillance platform for the Zika virus and microcephaly, Unified Health System (SUS) - Brazilian Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted with anonymized secondary data, where only aggregated clinical data was used for model parameterization (See institutional oversight body that says ethical approval was not required, attached as supplementary material). Therefore, no approval from a Human Research Ethics Committee is required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in Mathematical and Statistical Modeling of COVID-19 in Brazil at https://github.com/cidacslab/Mathematical-and-Statistical-Modeling-of-COVID19-in-Brazil. https://github.com/cidacslab/Mathematical-and-Statistical-Modeling-of-COVID19-in-Brazil